Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barre syndrome onset subsequent to Campylobacter jejuni enteritis
Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barre syndrome onset subsequent to Campylobacter jejuni enteritis
复制标题
DOI:
10.1016/s0022-510x(03)00029-7
复制
发表时间:
2003-06-15
影响因子:
4.4
通讯作者:
Hirata, K
中科院分区:
文献类型:
--
作者:
Odaka, M;Koga, M;Hirata, K
Anti-ganglioside antibodies frequently are present in sera from patients with Guillain-Barre syndrome (GBS) during the acute phase, but no patients in whom anti-ganglioside antibodies were tested before the onset of the syndrome have been reported. We describe the first case of GBS subsequent to Campylobacter jejuni infection, in which longitudinal changes in anti-ganglioside antibody titers were measured before and after the onset of limb weakness. Serum antibody titers against GM I (1gM/IgG), GM1b (IgM/IgG), GalNAc-GD1a (IgM/IgG), and GD1b(IgG) were highest on the day of onset, but negative before onset. Anti-C. jejuni IgG and IgA antibody titers paralleled those of the anti-ganglioside antibodies, indicative that C jejuni infection triggered anti-ganglioside antibody production. Press et a]. [J. Neurol. Sci. 190 (2001) 41] reported that anti-ganglioside antibody titers peaked during the recovery phase, but our findings are counter to theirs. We speculate that anti-ganglioside antibodies are the primary effectors of nerve damage in GBS. (C) 2003 Elsevier Science B.V. All rights reserved.